Patent ID: 8362020
Filing Date: 2013-01-29
Classification: A61K,A61P,C07D

Abstract:
1. A compound of Formula (I): or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein: Q L is a five-membered heterocyclyl group selected from the group consisting of wherein R x at each occurrence is independently hydrogen, halogen, or C 1-4 alkyl optionally substituted by —C(O)OR 3 or —NMe 2 , wherein R y at each occurrence is independently hydrogen or C 1-4 alkyl, and wherein R 3 is hydrogen or C 1-4 alkyl; R wherein any said heteroaryl may optionally be substituted with one or more substituents independently selected from C wherein any said cycloalkyl or heterocyclyl may optionally be fused onto an aromatic ring and may optionally be substituted with one or more substituents independently selected from C R R R R R R R L R R R R R R R